The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. (Q33984662)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821849%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

0 references

1 reference

Europe PubMed Central

The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821849%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

0 references

0 references

1 reference

based on heuristic

inferred from title

ejection fraction

1 reference

based on heuristic

inferred from title

PREDIMED Investigators

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821849%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)

1

1 reference

Europe PubMed Central

30 July 2017

publication date

6 August 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821849%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

European Heart Journal

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821849%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

33

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821849%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1750-1757

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821849%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821849%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Trends in prevalence and outcome of heart failure with preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Outcome of heart failure with preserved ejection fraction in a population-based study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Irbesartan in patients with heart failure and preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

N-terminal proatrial natriuretic peptide and prognosis in patients with heart failure and preserved systolic function

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Temporal improvement in heart failure survival related to the use of a nurse-directed clinic and recommended pharmacological treatment.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Left atrial enlargement and NT-proBNP as predictors of sudden cardiac death in patients with heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Heart failure with preserved left ventricular systolic function: a hospital cohort study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Survival of patients with a new diagnosis of heart failure: a population based study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Randomized, controlled trial of integrated heart failure management: The Auckland Heart Failure Management Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Clinical outcome of patients with heart failure and preserved left ventricular function.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Cardiopulmonary Exercise Testing in the Clinical and Prognostic Assessment of Diastolic Heart Failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Predictors of mortality in younger and older patients with heart failure and preserved or reduced left ventricular ejection fraction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

N-terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Prognosis in heart failure with preserved left ventricular systolic function: prospective cohort study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Systolic dysfunction is a predictor of long term mortality in men but not in women with heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Insights into the contemporary epidemiology and outpatient management of congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Ethnicity and variation in prognosis for patients newly hospitalised for heart failure: a matched historical cohort study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

A randomised trial of a pre-synaptic stimulator of DA2-dopaminergic and alpha2-adrenergic receptors on morbidity and mortality in patients with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Heart failure in patients with preserved and deteriorated left ventricular ejection fraction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

"Diastolic heart failure" or heart failure caused by subtle left ventricular systolic dysfunction?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Natural history of concentric left ventricular geometry in community-dwelling older adults without heart failure during seven years of follow-up

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Death in heart failure: a community perspective

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Why and when do patients with heart failure and normal left ventricular ejection fraction die? Analysis of >600 deaths in a community long-term study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Angiotensin-converting enzyme inhibitors prescription is associated with longer survival among patients hospitalized for congestive heart failure who have preserved systolic function: a long-term follow-up study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR254

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33984662&oldid=1866794918"